US OptionsDetailed Quotes
LLY250103P765000
- 0.03
- -1.57-98.13%
15min DelayClose Jan 3 16:00 ET
1.00High0.01Low
1.00Open1.60Pre Close400 Volume515 Open Interest765.00Strike Price3.79KTurnover704.17%IV2.18%PremiumJan 3, 2025Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type-0.0115Delta0.0040Gamma26066.00Leverage Ratio-149.1769Theta0.0000Rho-300.77Eff Leverage0.0003Vega
Eli Lilly and Co Stock Discussion
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
$Eli Lilly and Co (LLY.US)$
$Eli Lilly and Co (LLY.US)$
Nothing goes up forever, when it’s time for the fall, it just fall. You can lame it on FED or Powell but this pull back is a healthy one and an opportunity to buy the dip.
Once stable, we will probably see the the stocks trading around the same level until early next year. Hopefully by then the earnings season will provide some fuel for the stocks to move up.
$Eli Lilly and Co (LLY.US)$ $Tesla (TSLA.US)$ $Advanced Micro Devices (AMD.US)$ $Apple (AAPL.US)$ $Novo-Nordisk A/S (NVO.US)$ $Arm Holdings (ARM.US)$
...
No comment yet